Related Experiment Videos
[Association Budd Chiari syndrome, antiphospholipid syndrome and Grave's disease]
Leila Mouelhi1, Mouna Chaieb, Radhouane Debbeche
1Service de Gastro-entérologie, Hôpital Charles Nicolle, Tunis.
Background:
Antiphospholipid syndrome is revealed by Budd Chiari syndrome in 5% of the cases. Antiphospholipid syndrome is characterized by venous or arterial thrombosis, foetal loss and positivity of antiphospholipid antibodies, namely lupus anticoagulant, anticardiolipin antibodies and anti-beta2-glycoprotein I. Anticardiolipin antibodies was reported in auto-immune thyroid disorders, particularly in Grave's disease. Antiphospholipid syndrome associated to Grave's disease was reported in only three cases.
Aim:
To describe a case report of association of Grave's disease and antiphospholipid syndrome.
Observation:
We report the first case of Grave's disease associated with antiphospholipid syndrome, revealed by Budd Chiari syndrome.
Conclusion:
Our observation is particular by the fact that it is about a patient presenting a Grave's disease associated with antiphospholipid syndrome revealed by Budd Chiari syndrome. This triple association has never been reported in literature. Although association between antiphospholipid syndrome and Grave's disease was previously described, further studies evaluating the coexistence of these two affections in the same patient would be useful.
Related Concept Videos
Graves' Disease I: Introduction
Graves Disease II: Pathophysiology
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology
Portal Hypertension